302. レーベル遺伝性視神経症
［臨床試験数：20，薬物数：14（DrugBank：4），標的遺伝子数：5，標的パスウェイ数：32］
Searched query = "Leber hereditary optic neuropathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03153293 (ClinicalTrials.gov) | December 27, 2017 | 10/5/2017 | A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy | A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy | Leber Hereditary Optic Neuropathy | Drug: rAAV2-ND4 | Huazhong University of Science and Technology | Shiyan Taihe Hospital | Active, not recruiting | 10 Years | 65 Years | All | 159 | Phase 2;Phase 3 | China |
| 2 | NCT01267422 (ClinicalTrials.gov) | April 2011 | 27/12/2010 | Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON) | Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy | Leber Hereditary Optic Neuropathy | Drug: rAAV2-ND4 | Bin Li | Huazhong University of Science and Technology | Completed | 8 Years | 60 Years | All | 9 | N/A | China |